Evidence database

Best practice portal main page

Integrated care of infectious diseases and substance use disorders to improve infectious disease treatment outcomes

Summary of the evidence

Rating
  • Unknown effectiveness

A systematic review without meta-analysis  (Vold et al 2019, 7 RCT and 3 cohort studies, high risk of bias), found uncertain results on the effects of integrated care models on the treatment of infectious diseases in people with substance use disorders.

Details

Note: this evidence summary is only valid for the outcomes, target groups, settings and substances/patterns of use described below.

Name of response option
  • Integrated care
Desired outcome(s)
  • improve treatment outcomes
Area(s)
  • Treatment
Specific substance or pattern of use
  • alcohol
  • co-morbidity
  • not-drug specific
  • amphetamines
  • cannabis
  • cocaine
  • new psychoactive substances (NPS)
  • opioids
  • prescription medicines
  • tobacco
Target group(s) or setting(s)
  • communities
  • dual-diagnosis patients
  • emergency department
  • ethnic minority
  • families
  • law enforcement
  • pregnant women
  • PWID – people who inject drugs
  • school
  • women
  • prison
  • young people
  • partygoers/nightlife

References

Explore all resources in the Best practice portal

 

Miniguides

A one-stop-shop for anyone planning or delivering health and social responses.

 

Implementation

Implementation inventories including Xchange, Healthy Nightlife Toolbox, EUPC and EIB

 

Evidence

All of the latest research and evidence on drug-related interventions.

 

Standards

Standards and guidelines for drug-related interventions, aimed at improving their quality.

About the Best practice portal

Collaborations and partnerships in best practice

Logo of the Cochrane Collaboration
Logo of the Campbell Collaboration
Grade logo
WHO logo
Top